Journal of Biological Chemistry
Volume 278, Issue 35, 29 August 2003, Pages 33060-33066
Journal home page for Journal of Biological Chemistry

Protein Structure and Folding
Targeting a Surface Cavity of α1-Antitrypsin to Prevent Conformational Disease*

https://doi.org/10.1074/jbc.M302646200Get rights and content
Under a Creative Commons license
open access

Conformational diseases are caused by a structural rearrangement within a protein that results in aberrant intermolecular linkage and tissue deposition. This is typified by the polymers that form with the Z deficiency variant of α1-antitrypsin (Glu-342 → Lys). These polymers are retained within hepatocytes to form inclusions that are associated with hepatitis, cirrhosis, and hepatocellular carcinoma. We have assessed a surface hydrophobic cavity in α1-antitrypsin as a potential target for rational drug design in order to prevent polymer formation and the associated liver disease. The introduction of either Thr-114 → Phe or Gly-117 → Phe on strand 2 of β-sheet A within this cavity significantly raised the melting temperature and retarded polymer formation. Conversely, Leu-100 → Phe on helix D accelerated polymer formation, but this effect was abrogated by the addition of Thr-114 → Phe. None of these mutations affected the inhibitory activity of α1-antitrypsin. The importance of these observations was underscored by the finding that the Thr-114 → Phe mutation reduced polymer formation and increased the secretion of Z α1-antitrypsin from a Xenopus oocyte expression system. Moreover cysteine mutants within the hydrophobic pocket were able to bind a range of fluorophores illustrating the accessibility of the cavity to external agents. These results demonstrate the importance of this cavity as a site for drug design to ameliorate polymerization and prevent the associated conformational disease.

Cited by (0)

*

This work was supported in part by the Medical Research Council (UK), the Wellcome Trust, and Prof. G. Kerkut. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Wellcome Trust Advanced Clinical Fellow.

**

Recipient of the Pauline Thomas Memorial Trust.